These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26955002)

  • 1. The HeartMate II Risk Score: An Adjusted Score for Evaluation of All Continuous-Flow Left Ventricular Assist Devices.
    Cowger JA; Castle L; Aaronson KD; Slaughter MS; Moainie S; Walsh M; Salerno C
    ASAIO J; 2016; 62(3):281-5. PubMed ID: 26955002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Accuracy of the HeartMate Risk Score for Predicting Mortality Using the INTERMACS Registry Data.
    Kanwar MK; Lohmueller LC; Kormos RL; Loghmanpour NA; Benza RL; Mentz RJ; Bailey SH; Murali S; Antaki JF
    ASAIO J; 2017; 63(3):251-256. PubMed ID: 27984320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Heartmate Risk Score predicts morbidity and mortality in unselected left ventricular assist device recipients and risk stratifies INTERMACS class 1 patients.
    Adamo L; Nassif M; Tibrewala A; Novak E; Vader J; Silvestry SC; Itoh A; Ewald GA; Mann DL; LaRue SJ
    JACC Heart Fail; 2015 Apr; 3(4):283-90. PubMed ID: 25770410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HeartMate Risk Score Identifies Patients With Similar Mortality Risk Across All INTERMACS Profiles in a Large Multicenter Analysis.
    Adamo L; Tang Y; Nassif ME; Novak E; Jones PG; LaRue S; Spertus JA; Mann DL
    JACC Heart Fail; 2016 Dec; 4(12):950-958. PubMed ID: 27614939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: application of the HeartMate II risk score.
    Thomas SS; Nahumi N; Han J; Lippel M; Colombo P; Yuzefpolskaya M; Takayama H; Naka Y; Uriel N; Jorde UP
    J Heart Lung Transplant; 2014 Jul; 33(7):675-81. PubMed ID: 24726424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
    J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Value of EuroSCORE II in Patients Undergoing Left Ventricular Assist Device Therapy.
    Menon AK; Mechelinck M; Unterkofler J; Goetzenich A; Autschbach R; Tewarie L; Moza A
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):475-82. PubMed ID: 26501222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of Postoperative Risk Scores for Survival Prediction in Interagency Registry for Mechanically Assisted Circulatory Support Profile 1 Continuous-Flow Left Ventricular Assist Device Recipients.
    Critsinelis AC; Lamba HK; Nguyen MT; Conroy JR; Cheema FH; Civitello AB; Delgado RM; Nair AP; Oberton SB; Rosengart TK; Frazier OH; Morgan JA; Chatterjee S
    ASAIO J; 2020 May; 66(5):539-546. PubMed ID: 31335367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durable Biventricular Support Using Right Atrial Placement of the HeartWare HVAD.
    Tran HA; Pollema TL; Silva Enciso J; Greenberg BH; Barnard DD; Adler ED; Pretorius VG
    ASAIO J; 2018; 64(3):323-327. PubMed ID: 28841580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial.
    Najjar SS; Slaughter MS; Pagani FD; Starling RC; McGee EC; Eckman P; Tatooles AJ; Moazami N; Kormos RL; Hathaway DR; Najarian KB; Bhat G; Aaronson KD; Boyce SW;
    J Heart Lung Transplant; 2014 Jan; 33(1):23-34. PubMed ID: 24418731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-Operative Right Ventricular Dysfunction Is Associated With Gastrointestinal Bleeding in Patients Supported With Continuous-Flow Left Ventricular Assist Devices.
    Sparrow CT; Nassif ME; Raymer DS; Novak E; LaRue SJ; Schilling JD
    JACC Heart Fail; 2015 Dec; 3(12):956-64. PubMed ID: 26577618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).
    Jorde UP; Kushwaha SS; Tatooles AJ; Naka Y; Bhat G; Long JW; Horstmanshof DA; Kormos RL; Teuteberg JJ; Slaughter MS; Birks EJ; Farrar DJ; Park SJ;
    J Am Coll Cardiol; 2014 May; 63(17):1751-7. PubMed ID: 24613333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival results after implantation of intrapericardial third-generation centrifugal assist device: an INTERMACS-matched comparison analysis.
    Dell'Aquila AM; Schneider SR; Stypmann J; Ellger B; Redwan B; Schlarb D; Martens S; Sindermann JR
    Artif Organs; 2014 May; 38(5):383-90. PubMed ID: 24117675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial clinical experience with the HeartWare left ventricular assist system: a single-center report.
    Dell'Aquila AM; Schneider SR; Schlarb D; Redwan B; Sindermann JR; Ellger B; Stypmann J; Tjan TD; Scheld HH; Hoffmeier A
    Ann Thorac Surg; 2013 Jan; 95(1):170-7. PubMed ID: 23141906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrovascular Events in Patients With Centrifugal-Flow Left Ventricular Assist Devices: Propensity Score-Matched Analysis From the Intermacs Registry.
    Cho SM; Mehaffey JH; Meyers SL; Cantor RS; Starling RC; Kirklin JK; Jacobs JP; Kern J; Uchino K; Yarboro LT
    Circulation; 2021 Sep; 144(10):763-772. PubMed ID: 34315231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional differences in use and outcomes of left ventricular assist devices: Insights from the Interagency Registry for Mechanically Assisted Circulatory Support Registry.
    Krim SR; Vivo RP; Campbell P; Estep JD; Fonarow GC; Naftel DC; Ventura HO
    J Heart Lung Transplant; 2015 Jul; 34(7):912-20. PubMed ID: 25824553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score.
    Cowger J; Sundareswaran K; Rogers JG; Park SJ; Pagani FD; Bhat G; Jaski B; Farrar DJ; Slaughter MS
    J Am Coll Cardiol; 2013 Jan; 61(3):313-21. PubMed ID: 23265328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrovascular Events in Patients With Centrifugal-Flow Left Ventricular Assist Devices: Propensity Score-Matched Analysis From the Intermacs Registry.
    Cho SM; Mehaffey JH; Meyers SL; Cantor RS; Starling RC; Kirklin JK; Jacobs JP; Kern J; Uchino K; Yarboro LT
    Circulation; 2021 Sep; 144(10):763-772. PubMed ID: 34491776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.